Format

Send to

Choose Destination
PLoS One. 2019 Mar 8;14(3):e0213428. doi: 10.1371/journal.pone.0213428. eCollection 2019.

Citrulline protects mice from experimental cerebral malaria by ameliorating hypoargininemia, urea cycle changes and vascular leak.

Author information

1
La Jolla Infectious Disease Institute, San Diego, CA, United States of America.
2
Chang-Gung University, Taipei, Taiwan.
3
WCW Biostatistical Consulting, Aylesbury, United Kingdom.
4
School of Life Sciences, University of Technology Sydney, Sydney, Australia.
5
Vascular Immunology Unit, University of Sydney, Sydney, Australia.
6
Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States of America.

Abstract

Clinical and model studies indicate that low nitric oxide (NO) bioavailability due in part to profound hypoargininemia contributes to cerebral malaria (CM) pathogenesis. Protection against CM pathogenesis may be achieved by altering the diet before infection with Plasmodium falciparum infection (nutraceutical) or by administering adjunctive therapy that decreases CM mortality (adjunctive therapy). This hypothesis was tested by administering citrulline or arginine in experimental CM (eCM). We report that citrulline injected as prophylaxis immediately post infection (PI) protected virtually all mice by ameliorating (i) hypoargininemia, (ii) urea cycle impairment, and (iii) disruption of blood brain barrier. Citrulline prophylaxis inhibited plasma arginase activity. Parasitemia was similar in citrulline- and vehicle control-groups, indicating that protection from pathogenesis was not due to decreased parasitemia. Both citrulline and arginine administered from day 1 PI in the drinking water significantly protected mice from eCM. These observations collectively indicate that increasing dietary citrulline or arginine decreases eCM mortality. Citrulline injected ip on day 4 PI with quinine-injected ip on day 6 PI partially protected mice from eCM; citrulline plus scavenging of superoxide with pegylated superoxide dismutase and pegylated catalase protected all recipients from eCM. These findings indicate that ameliorating hypoargininemia with citrulline plus superoxide scavenging decreases eCM mortality.

Conflict of interest statement

Wilson Caparros-Wanderley is employed by WCW Biostatistical Consulting. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center